Contract Development Services

Dec 02, 2011
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Drug shortages, supply-chain security, generic-drug incursion, and flexible manufacturing models are some of the issues shaping the bio/pharma industry.
Dec 02, 2011
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Expansion activity was limited as fine-chemical producers and CMOs of API and intermediates grapple with changing industry fundamentals.
Oct 02, 2011
Pharmaceutical Technology
The global excipients market shows moderate growth, increased consolidation, and expansion activity in emerging markets and select product areas.
Sep 02, 2011
Pharmaceutical Technology
Biocatalysis, chemocatalysis, and other chiral technologies continue to attract the investment dollars of CMOs and fine-chemical companies.
Sep 01, 2011
Pharmaceutical Technology
By Pharmaceutical Technology Editors
As contract manufacturers and fine-chemical suppliers gather for CPhI/ICSE, effective strategies for technology differentiation are key in an increasingly competitive environment.
Sep 01, 2011
Pharmaceutical Technology Europe
The increased trend of outsourcing coupled with a relatively strong economy has seen the fine chemicals market grow at a very high level when compared to historical data.
Aug 01, 2011
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Avantor reviews its experience with the Rx-360 shared audit pilot program, which is aimed at protecting the pharmaceutical supply chain. This article is part of a special issue on Outsourcing.
Jun 02, 2011
Pharmaceutical Technology
A recent industry survey shows keen interest in improving bioreactors and cell-culture media.
Apr 02, 2011
Pharmaceutical Technology
Chemocatalytic and biocatalytic routes play an important role in improving the manufacture of intermediates and active pharmaceutical ingredients.
native1_300x100
lorem ipsum